SR-9009 Stenabolic 20mg/mL Liquid (PPAR Alpha Modulator)

الوصف

SR-9009 Stenabolic 20mg/mL Liquid 99.60% purity Dropper measures 20 drops per 1mL. Plunger measures 1mL (100 units) in 0.01mL (1 unit) increments. SR9009 also known as Stenabolic is a research drug that was developed by Professor Thomas Burris of the Scripps Research Institute as an agonist of Rev-ErbA (i.e., increases the constitutive repression of genes regulated by Rev-ErbA) with a half-maximum inhibitory concentration (IC50) = 670 nM for Rev-ErbAα and IC50 = 800 nM for Rev-ErbAβ. THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS INTENDED FOR RESEARCH PURPOSES ONLY